Exogenous surfactant and nitric oxide have a synergistic effect in improving gas exchange in experimental ARDS

Advances in Experimental Medicine and Biology

Volumn 428, Issue , 1997, Pages 277-279

  Hartog, A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LUNG SURFACTANT; NITRIC OXIDE;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL OXYGEN TENSION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG POTENTIATION; INHALATIONAL DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; LUNG GAS EXCHANGE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0031423184     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5399-1_38     Document Type: Conference Paper

References (4)

1. Abman SH. Inhaled nitric oxide therapy in neonatal and pediatric cardiorespiratory disease. In:Tibboel D, van der Voort E (eds). Update in Intensive Care & Emerg Med 25. Springer 1996: 322-336.
2. Finer NN, Etches PC, Kamstra B, Tierney AJ, Peliowski A, Ryan CA. Inhaled nitric oxide in infants refered for extracorporal membrane oxygenation: dose response. J Pediatr 1994; 124: 302-308.
3. Gaston B, Drazen JM, Loscalzo J, Stamler JS. The biology of nitrogen oxides in the airways. Am J Resp Crit Care Med 1994; 149: 538-551.
4. Gommers D, Lachmann B: Surfactant therapy: does it have a role in adults? Clinical Intensive Care 1993; 4: 284-295.